Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Advancements In The Cystic Fibrosis Therapeutics Treatment
3.2.2. Increasing Incidence Of Cystic Fibrosis (Cf)
3.2.3. Rise In The R&D Of Novel Cystic Fibrosis Therapeutics
3.3. Key Restraints
3.3.1. Stringent Regulation
3.3.2. Low Awareness Among Developing Economies

4. Key Analytics
4.1. Porter’S Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Pestel Analysis
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Route Of Administration
5.1. Inhale
5.2. Oral

6. Market By Drug Class
6.1. Cftr Modulators
6.2. Bronchodilators
6.3. Mucolytic
6.4. Pancreatic Enzyme Supplements

7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Italy
7.1.5. Russia
7.1.6. Belgium
7.1.7. Poland
7.1.8. Rest Of Europe

8. Company Profiles
8.1. Abbott Laboratories
8.2. Abbvie Inc
8.3. Agilent Technologies Inc
8.4. Allergan Plc
8.5. F. Hoffmann-La Roche
8.6. Gilead Sciences Inc
8.7. Glaxosmithkline Plc
8.8. Johnson & Johnson
8.9. Mylan N.V
8.10. Novartis Ag
8.11. Perkinelmer
8.12. Pfizer Inc
8.13. Pharmaxis Ltd
8.14. Teva Pharmaceutical Industries Ltd
8.15. Vertex Pharmaceuticals Incorporated



List of Figures


List of Figures

Figure 1: Porter’S Five Forces Analysis
Figure 2: Opportunity Matrix
Figure 3: Vendor Landscape
Figure 4: Key Investment Insights
Figure 5: Europe Cystic Fibrosis Therapeutics, By Route Of Administration, In 2019
Figure 6: Europe Cystic Fibrosis Therapeutics Market, By Inhale, 2020-2028 (In $ Million)
Figure 7: Europe Cystic Fibrosis Therapeutics Market, By Oral, 2020-2028 (In $ Million)
Figure 8: Europe Cystic Fibrosis Therapeutics, By Drug Class, In 2019
Figure 9: Europe Cystic Fibrosis Therapeutics Market, By Cftr Modulators, 2020-2028 (In $ Million)
Figure 10: Europe Cystic Fibrosis Therapeutics Market, By Bronchodilators, 2020-2028 (In $ Million)
Figure 11: Europe Cystic Fibrosis Therapeutics Market, By Mucolytic, 2020-2028 (In $ Million)
Figure 12: Europe Cystic Fibrosis Therapeutics Market, By Pancreatic Enzyme Supplements, 2020-2028 (In $ Million)
Figure 13: Europe Cystic Fibrosis Therapeutics Market, Country Outlook, 2019 & 2028 (In %)
Figure 14: The United Kingdom Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 15: France Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 16: Germany Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 17: Italy Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 18: Russia Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 19: Belgium Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 20: Poland Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)
Figure 21: Rest Of Europe Cystic Fibrosis Therapeutics Market, 2020-2028 (In $ Million)


List of Tables


List of Tables

TABLE 1: MARKET SNAPSHOT - VETERINARY VACCINE
TABLE 2: EUROPE CYSTIC FIBROSIS THERAPEUTICS, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 3: EUROPE CYSTIC FIBROSIS THERAPEUTICS, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: EUROPE INHALE MARKET, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 5: EUROPE INHALE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: EUROPE ORAL MARKET, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 7: EUROPE ORAL MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: EUROPE CYSTIC FIBROSIS THERAPEUTICS, BY DRUG CLASS, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 9: EUROPE CYSTIC FIBROSIS THERAPEUTICS, BY DRUG CLASS, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: EUROPE CFTR MODULATORS MARKET, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 11: LIST OF CFTR MODULATORS GENERIC AND BRAND NAME
TABLE 12: EUROPE CFTR MODULATORS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 13: EUROPE BRONCHODILATORS MARKET, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 14: LIST OF BRONCHODILATORS GENERIC AND BRAND NAME
TABLE 15: EUROPE BRONCHODILATORS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 16: EUROPE MUCOLYTIC MARKET, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 17: LIST OF MUCOLYTICS GENERIC AND BRAND NAME
TABLE 18: EUROPE MUCOLYTIC MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 19: EUROPE PANCREATIC ENZYME SUPPLEMENTS MARKET, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 20: EUROPE PANCREATIC ENZYME SUPPLEMENTS MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 21: EUROPE CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016 -2019 (IN $ MILLION)
TABLE 22: EUROPE CYSTIC FIBROSIS THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION):